This summary is based on a press release distributed by the Mount Sinai Press Office on
October 29, 2025.
October 29, 2025.
We’re thrilled to share that Mount Sinai Tisch Cancer Center has officially launched a
groundbreaking real-time data integration initiative — powered by IgniteData’s Archer platform
— transforming how clinical trial data moves between systems and reshaping what’s possible in
cancer research.
Through this collaboration, Mount Sinai has become one of the first major U.S. research
institutions to enable automated, real-time data transfer from its Epic electronic health record
(EHR) directly into clinical trial databases. The result? Manual re-entry is virtually eliminated,
dramatically increasing data accuracy, speed, and efficiency.
Early results are remarkable — research teams have reported up to a 70% reduction in manual
data transcription time, freeing staff to focus more on patients and less on paperwork. Built on
HL7® FHIR® standards, the integration ensures data flows securely and seamlessly, enhancing
quality while supporting faster safety reviews and regulatory submissions.
Mount Sinai leaders describe this as a major leap forward in research infrastructure and patient
access to clinical trials — aligning perfectly with the Cancer Center’s NCI Comprehensive
designation and its reputation for innovation and operational excellence.
At IgniteData, we’re proud to see Archer’s real-world impact in action — empowering leading
institutions like Mount Sinai to accelerate discovery, advance patient care, and bring life-
changing therapies to those who need them faster.